Showing results (111-120 of 163) with videos related to
Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|January 21, 2010
Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006Elizabeth M Brown, David N Fisman, Steven J Drews, et al.Ecohealth|December 3, 2009
Environmental determinants of campylobacteriosis risk in Philadelphia from 1994 to 2007Alexander N J White, Laura M Kinlin, Caroline Johnson, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 24, 2021
Socio-demographic disparities in knowledge, practices, and ability to comply with COVID-19 public health measures in CanadaGabrielle Brankston, Eric Merkley, David N Fisman, et al.Lancet Regional Health. Americas|June 19, 2025
Derivation and validation of a point-based forecasting tool for SARS-CoV-2 critical care occupancy: a population-based modeling studyAlicia A Grima, Clara Eunyoung Lee, Ashleigh R Tuite, et al.American Journal of Epidemiology|January 24, 2009
Environmental exposures and invasive meningococcal disease: an evaluation of effects on varying time scalesLaura M Kinlin, C Victor Spain, Victoria Ng, et al.BMC Public Health|November 9, 2021
Quantifying contact patterns in response to COVID-19 public health measures in CanadaGabrielle Brankston, Eric Merkley, David N Fisman, et al.BMC Infectious Diseases|December 8, 2009
Let the sun shine in: effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, PennsylvaniaAlexander N J White, Victoria Ng, C Victor Spain, et al.Journal of Neurosurgery|September 10, 2003
Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson diseaseGalit Kleiner-Fisman, David N Fisman, Elspeth Sime, et al.Plos One|November 25, 2010
Respiratory virus infection and risk of invasive meningococcal disease in central Ontario, CanadaAshleigh R Tuite, Laura M Kinlin, Stefan P Kuster, et al.Plos Currents|January 1, 2010
Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian ExperienceBeate Sander, Chris Bauch, David N Fisman, et al.Pageof 17